| [1] | Min R., Bai Y., Wang N., et al. (2025). Gasdermins in pyroptosis, inflammation, and cancer. Trends Mol. Med. 31:860–875. DOI: 10.1016/j.molmed.2025.04.003 |
| [2] | Ding J., Wang K., Liu W., et al. (2016). Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535: 111-116. DOI:10.1038/nature18590 |
| [3] | Shi J., Zhao Y., Wang K., et al. (2015). Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526:660-665. DOI:10.1038/nature15514 |
| [4] | Kayagaki N., Stowe IB., Lee BL., et al. (2015). Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526:666-671. DOI:10.1038/nature15541 |
| [5] | Sun J., Yang J., Tao J., et al. (2025). Delaying pyroptosis with an AI-screened gasdermin D pore blocker mitigates inflammatory response. Nat. Immunol. 26:1660-1672. DOI:10.1038/s41590-025-02280-x |
| Wang W., Liang Q. and Wang C. (2026). Targeting GSDMD-mediated pyroptosis: An AI-guided peptide discovery. The Innovation Life 4:100194. https://doi.org/10.59717/j.xinn-life.2026.100194 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Schematic of AI-Driven peptide drug design and validation workflow for undruggable proteins.